Q86 · Healthcare · Global
Oncology medicine spending at list prices
Global: 252 billion USD in 2024. IQVIA projects 441 billion USD for 2029.
- 252 billion USD Latest · Global · 2024
- Annual Release cadence
- 2 Records · 1 region · 2024–2029
Verified 17 Sep 2026 · 1 publisher · Next period 2025
Over time
Global over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Oncology medicine spending at list prices
Global, 2024 to 2029
Forecast: dashed line, hollow markers, shaded band
Forecasts are dashed, with hollow markers.
Every record
2 records · 1 region · 2024–2029. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: IQVIA. Licence: CC BY 4.0.
Embed this chart
For automatic sizing and multiple charts, see the JavaScript embed guide.
Free to embed anywhere, including commercially. The attribution bar is part of the chart. The link under the frame is optional: keep it, remove it or mark it rel="nofollow".
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (IQVIA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Total spending on cancer medicines valued at list prices.
- Measure
- One slice of Medicine spending ( basis: list prices, form: level, segment: oncology ) . Total expenditure on pharmaceutical products and therapies. Region and period are columns on every record, not slices.
- Limitations
- 1 figure is a projection, drawn dashed and labelled in the table. Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global Oncology Trends 2025 | IQVIA | — | 2 |
Other slices of medicine spending
- Cell and gene therapy spending share by geography 2 cell and gene therapy
- Net medicine spending 2 net prices
- Net medicine spending growth rate 2 net prices
- COVID-19 vaccines and therapeutics spending decline 1 covid 19 vaccines and therapeutics
- Cell and gene therapy share of medicine spending 1 cell and gene therapy
- Cell and gene therapy spending 1 cell and gene therapy
- Cell and gene therapy spending average annual growth rate 1 cell and gene therapy
- Cell and gene therapy spending growth rate 1 cell and gene therapy
- Cell and gene therapy spending year-over-year growth 1 cell and gene therapy
- GIP/GLP-1 agonist spending growth contribution 1 gip glp 1 agonist
- High GDP developed countries medicine spending growth 1
- Innovative medicines spending target share of GDP 1 innovative
Frequently asked questions
What is the latest oncology medicine spending at list prices?
Global: 252 billion USD in 2024. IQVIA projects 441 billion USD for 2029.
Where does this data come from?
From 1 document published by IQVIA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Annual. The newest published period is 2024; the next release should cover 2025. A new figure appears here once the publisher releases it and it passes verification.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Oncology medicine spending at list prices [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/oncology-medicine-spending-at-list-prices
"Oncology medicine spending at list prices." StatOrigin, 2026, https://statorigin.org/indicators/oncology-medicine-spending-at-list-prices. Accessed 28 Oct. 2026.
StatOrigin. "Oncology medicine spending at list prices." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/oncology-medicine-spending-at-list-prices.
@misc{statorigin_oncology_medicine_spending_at_list_prices_2026, title = {Oncology medicine spending at list prices}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/oncology-medicine-spending-at-list-prices}, note = {Data set. Accessed 2026-10-28} }